Skip to content
value.today

Immuron Ltd vs Regenxbio Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Regenxbio Inc. is the larger company by market value: $513 M against $9 M for Immuron Ltd, 57 times as much (market caps of Aug 1, 2026 for Immuron Ltd and Oct 6, 2026 for Regenxbio Inc.). Immuron Ltd's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
  • Regenxbio Inc. had more revenue: $170 M in the year to December 2025 against $5 M for Immuron Ltd in the year to June 2025.
  • Both made a net loss: $3 M for Immuron Ltd and $194 M for Regenxbio Inc.
  • Immuron Ltd keeps more of each dollar of sales: a net margin of -71.6% against -113.8% for Regenxbio Inc.
  • Regenxbio Inc.'s revenue grew faster in its latest fiscal year: +104.5% against +47.0% for Immuron Ltd.
  • Both are in the distress zone of the Altman Z-score.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0631251882502020202120222023202420252026Immuron Ltd 56Regenxbio Inc. 35

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B201720182019202020212022202320242025Immuron Ltd $0BRegenxbio Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureImmuron Ltd
IMRN · #26,015 in the world
Regenxbio Inc.
RGNX · #12,428 in the world
Profile
Country🇦🇺 Australia🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded——
Size
Market cap$9 M$513 M
Revenue$5 M$170 M
Net income$-3 M▲ best$-194 M
Employees—372
Valuation
Price to sales1.9×3.3×
Price to book1.7×5.0×
Free cash flow yield-42.8%-24.6%▲ best
Profitability
Gross margin65.5%—
Operating margin-73.3%▲ best-94.6%
Net margin-71.6%▲ best-113.8%
Return on equity-49.2%▲ best-107.0%
Growth
Revenue growth47.0%104.5%▲ best
Revenue growth, 3 years a year103.5%▲ best14.8%
Cash
Free cash flow margin—-74.1%
Altman Z-score zonedistressdistress
Data as ofMarket cap Aug 2026; ratios FY2025Market cap Oct 2026; ratios FY2025

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Immuron Ltd or Regenxbio Inc.?

Regenxbio Inc. is the larger company by market value: $513 M against $9 M for Immuron Ltd, 57 times as much (market caps of Aug 1, 2026 for Immuron Ltd and Oct 6, 2026 for Regenxbio Inc.). Immuron Ltd's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.

Which makes more money, Immuron Ltd or Regenxbio Inc.?

Regenxbio Inc. had more revenue: $170 M in the year to December 2025 against $5 M for Immuron Ltd in the year to June 2025. Both made a net loss: $3 M for Immuron Ltd and $194 M for Regenxbio Inc.

Which is more profitable, Immuron Ltd or Regenxbio Inc.?

Immuron Ltd keeps more of each dollar of sales: a net margin of -71.6% against -113.8% for Regenxbio Inc.

Which is growing faster, Immuron Ltd or Regenxbio Inc.?

Regenxbio Inc.'s revenue grew faster in its latest fiscal year: +104.5% against +47.0% for Immuron Ltd.

Which is financially stronger, Immuron Ltd or Regenxbio Inc.?

Both are in the distress zone of the Altman Z-score.

Sources#

Every figure on this page comes from these, with the date shown next to it.